Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigulixostat vs Febuxostat in Chinese Subjects With Gout
NCT07414394Phase 3Active, not recruiting
- Sponsor
- Innovent Biologics
- Start
- Mar 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tigulixostat in gout, sponsored by Innovent Biologics. Started Mar 2026; status: active, not recruiting.
02
Drugs
tigulixostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT07414394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07414394.